Virtual Industry Workshop on NGS-Based Biosafety Testing, co-hosted by BMS
The aim of the second edition of this exclusive event is to bring together experts, to facilitate knowledge sharing, and industry discussions around the key challenges and opportunities in the fast-evolving area of biosafety testing.
We are delighted to announce that our host will be Dr. Anurag Khetan, Executive Director, Global Upstream and CLD, Biologics Development at Bristol-Myers Squibb. Anurag has over 20 years of industry experience in biologics R&D, having served in various positions at Merck, Biogen and Boehringer Ingelheim.
This invitation-only event is limited to industry participants and is free to attend.
“The purpose of our gathering and discussions is to start a pre-competitive R&D collaboration and discuss best practices using NGS-based biosafety to identify adventitious agents during biopharma R&D. We consider our discussions to be pre-competitive in nature as the best practices can be used very broadly in the industry. Please keep the conversation to this topic and refrain from bringing up topics that could be considered anti-competitive under antitrust/competition laws, such as pricing.”